Furthermore, the consistent presence of the PRDM16 variant in affected family members, and its absence in non-affected family members, combined with a strong maternal family history of cardiomyopathy, provides compelling support for the pathogenicity of the PRDM16 variant. This evidence concerns the gene PRDM16 and cardiomyopathy.